FORM OF WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES ASLAN Pharmaceuticals LimitedASLAN Pharmaceuticals LTD • March 13th, 2024 • Pharmaceutical preparations
THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”), issued in the form of uncertificated securities, certifies that, for value received, ______ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______, 2029 (the “Termination Date”) but not thereafter, to subscribe for and purchase from ASLAN Pharmaceuticals Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), up to ______ Ordinary Shares, nominal or par value $0.01 per share (as subject to adjustment hereunder) (the “Warrant Shares”), represented by _________ American Depositary Shares (“ADSs”), each twenty-five (25) Ordinary Shares represented by one (1) ADS (as subject to adjustment hereunder) (the “Warrant AD
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 13th, 2024 • ASLAN Pharmaceuticals LTD • Pharmaceutical preparations • New York
This Securities Purchase Agreement (this “Agreement”), dated as of March 12, 2024, is between ASLAN Pharmaceuticals Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
